A detailed history of Bank Of America Corp transactions in Care Dx, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 250,581 shares of CDNA stock, worth $6.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250,581
Previous 168,473 48.74%
Holding current value
$6.8 Million
Previous $1.78 Million 118.11%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.56 - $16.15 $620,736 - $1.33 Million
82,108 Added 48.74%
250,581 $3.89 Million
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $524,014 - $814,329
-65,831 Reduced 28.1%
168,473 $1.78 Million
Q4 2023

Feb 14, 2024

SELL
$4.9 - $12.86 $1.04 Million - $2.74 Million
-212,690 Reduced 47.58%
234,304 $2.81 Million
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $484,064 - $601,741
-63,609 Reduced 12.46%
446,994 $3.8 Million
Q1 2023

May 12, 2023

SELL
$8.83 - $17.61 $35,434 - $70,668
-4,013 Reduced 0.78%
510,603 $4.67 Million
Q4 2022

Feb 10, 2023

BUY
$10.88 - $20.05 $1.94 Million - $3.57 Million
178,221 Added 52.98%
514,616 $5.87 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $995,222 - $1.64 Million
61,969 Added 22.58%
336,395 $5.73 Million
Q2 2022

Aug 12, 2022

SELL
$20.49 - $39.72 $8,933 - $17,317
-436 Reduced 0.16%
274,426 $5.89 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $2.88 Million - $4.76 Million
102,189 Added 59.18%
274,862 $10.2 Million
Q4 2021

Feb 08, 2022

BUY
$41.2 - $73.6 $492,422 - $879,667
11,952 Added 7.44%
172,673 $7.85 Million
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $584,224 - $908,585
-9,877 Reduced 5.79%
160,721 $10.2 Million
Q2 2021

Sep 13, 2021

BUY
$63.02 - $95.11 $10.8 Million - $16.2 Million
170,598 New
170,598 $15.6 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.45B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.